However, I eventually started experiencing sporadic bouts of debilitating back pain. Every six months or so, I woke up with a ...

Discure Technologies announced today that it raised $11 million in an oversubscribed Series A, adding to a separate $5 ...

Discure Technologies has raised $16 million in Series A funding for the development of a bioelectronic implantable device for the treatment of degenerative disc disease.

Slouching or overextending your back while riding can lead to muscle strain and spinal discomfort. Prioritize proper bike fit ...

Israeli bioelectronic implantable device for the treatment of degenerative disc disease (DDD) company Discure Technologies ...

Here are seven orthopedic and spine devicemakers that have raised series A and series C funding this year, totaling $283.5 million: 1. Discure Technologies raised $16 million in Series A funding for ...

Theradaptive, Inc., a market leader in targeted regenerative therapeutics, today announced that the first patient has been ...

Signs and symptoms in people later identified as having CTE have been described as similar to neurodegenerative diseases, such as Alzheimer's disease or dementia. Clarity on causes of these other ...

Signs and symptoms in people later identified as having CTE have been described as similar to neurodegenerative diseases, such as Alzheimer’s disease or dementia. Clarity on causes of these ...

The global spine biologics market size is calculated at USD 4.42 billion in 2024 and is expected to achieve around USD 6.95 ...